ImmuPharma plc

ImmuPharma plcverified

IMM.L

ImmuPharma plc, a biopharmaceutical company, discovers and develops peptide-based therapeutics. Its peptide-based therapeutics are used in the therapy areas of autoimmunity and inflammation, and anti-infectives. The company's lead product candidate is the Lupuzor, an autophagy immunomodulator, which is in Phase III clinical trial for the treatment of lupus, an autoimmune chronic inflammatory disease. Its other product candidates include BioAMB, a peptide-based drug for the treatment of Amphotericin-B formulations, a fungal infection caused by the aspergillus family of fungi; and BioCin, a peptide-based antibacterial drug used in high medical need cases and in last line of defense. The compan...[Read more]

Industry

Biotechnology

IPO Date

2003-10-28

Stock Exchange

LSE

Ticker

IMM.L

The Enterprise Value as of December 2025 (TTM) for ImmuPharma plc (IMM.L) is 30.05M

According to ImmuPharma plc’s latest financial reports and current stock price. The company's current Enterprise Value is 30.05M. This represents a change of 225.51% compared to the average of 9.23M of the last 4 quarters.

ImmuPharma plc (IMM.L) Historical Enterprise Value (quarterly & annually)

How has IMM.L Enterprise Value performed in the past?

The mean historical Enterprise Value of ImmuPharma plc over the last ten years is 41.72M. The current 30.05M Enterprise Value has changed 7.10% with respect to the historical average. Over the past ten years (40 quarters), IMM.L's Enterprise Value was at its highest in in the December 2017 quarter at 247.56M. The Enterprise Value was at its lowest in in the December 2024 quarter at 4.80M.

Quarterly (TTM)
Annual

Average

41.72M

Median

18.20M

Minimum

4.77M

Maximum

244.94M

ImmuPharma plc (IMM.L) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of ImmuPharma plc Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 311.89%

Maximum Annual Enterprise Value = 244.94M

Minimum Annual Increase = -95.30%

Minimum Annual Enterprise Value = 4.77M

Quarterly (TTM)
Annual
YearEnterprise ValueChange
20244.77M-17.95%
20235.82M18.54%
20224.91M-67.14%
202114.93M-30.50%
202021.48M-7.47%
201923.21M101.46%
201811.52M-95.30%
2017244.94M311.89%
201659.47M127.10%
201526.18M-31.11%

ImmuPharma plc (IMM.L) Average Enterprise Value

How has IMM.L Enterprise Value performed in the past?

The current Enterprise Value of ImmuPharma plc (IMM.L) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages

3-year avg

5.16M

5-year avg

10.38M

10-year avg

41.72M

ImmuPharma plc (IMM.L) Enterprise Value vs. Peers

How is IMM.L’s Enterprise Value compared to its peers?

ImmuPharma plc’s Enterprise Value is less than Ondine Biomedical Inc. (71.33M), less than Hemogenyx Pharmaceuticals Plc (37.91M), greater than hVIVO plc (5.83M), less than SkinBioTherapeutics Plc (34.72M), greater than Creo Medical Limited (24.97M), greater than Arecor Therapeutics plc (29.04M), greater than Kooth plc (27.97M), less than INSPECS Group plc (119.37M), less than ECO Animal Health Group plc (50.99M), greater than Poolbeg Pharma PLC (16.53M),

Build a custom stock screener for ImmuPharma plc (IMM.L) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like ImmuPharma plc using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

ImmuPharma plc (IMM.L) and other stocks custom spreadsheet templates

The easiest way to analyze a company like ImmuPharma plc or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is ImmuPharma plc's Enterprise Value?

What is the highest Enterprise Value for ImmuPharma plc (IMM.L)?

What is the 3-year average Enterprise Value for ImmuPharma plc (IMM.L)?

What is the 5-year average Enterprise Value for ImmuPharma plc (IMM.L)?

How does the current Enterprise Value for ImmuPharma plc (IMM.L) compare to its historical average?